TXNIP and hepatocellular carcinoma: In addition, the data from TCGA was exploited for Kaplan–Meier analysis of clinical outcome and the result showed that downregulation of TXNIP was significantly (P = 0.015) associated with a poorer prognosis for HCC patients (Fig. 4G).